Vivos (RDGL) Payables (2010 - 2025)

Vivos (RDGL) posted Payables of $92472.0 for Q4 2025, down 17.94% sequentially from $112693.0 in Q3 2025, and up 7.26% YoY from $86209.0 in Q4 2024.

Vivos (RDGL) Payables (2010 - 2025) Analysis & Trends

Vivos has reported Payables for 16 years, with the latest figure at $92472.0 in Q4 2025.

Quarterly Payables rose 7.26% year-over-year to $92472.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $92472.0 (up 7.26% YoY) and the FY2025 annual result came in at $92472.0, up 7.26% from the prior year.
Payables declined to $92472.0 in Q4 2025 per RDGL's latest filing, from $112693.0 in the prior quarter.
Over five years, Payables peaked at $443345.0 in Q1 2021 and troughed at $48820.0 in Q3 2024.
A 5-year average of $145891.5 and a median of $112751.5 in 2023 frame the typical range for Payables.
The sharpest annual moves came in 2021 and 2022: Payables surged 2855.63% in 2021, then tumbled 80.71% in 2022.
Over 5 years, Payables stood at $166915.0 in 2021, then tumbled by 51.06% to $81692.0 in 2022, then surged by 199.91% to $245004.0 in 2023, then slumped by 64.81% to $86209.0 in 2024, then gained by 7.26% to $92472.0 in 2025.
According to Business Quant data, Payables over the past three periods registered $92472.0, $112693.0, and $96458.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Payables (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn	5.89 Bn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn	2.00 Bn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn	2.64 Bn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn	1.23 Bn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn	210.50 Mn
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn	3.23 Bn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn	2.51 Bn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn	587.50 Mn
10	Vivos	24.08 Mn	22.53 Mn	-3,105.00	92,472.00

Download Data